UBS Group’s Rennova Health, Inc. RNVA Stock Holding History

UBS Group’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,218	Closed	-$6K	–	8434
2017 Q3	$6K	Buy	2,218 +596	+37%	+$2.55K	﹤0.01%	7190
2017 Q2	$9K	Buy	+1,622	New	+$17.2K	﹤0.01%	6880
2016 Q4	–	Sell	-29	Closed	-$2K	–	8309
2016 Q3	$2K	Buy	29 +26	+867%	+$3.41K	﹤0.01%	7466
2016 Q2	$1K	Hold	3	–	–	﹤0.01%	7626
2016 Q1	$1K	Sell	3 -2	-40%	-$735	﹤0.01%	7518
2015 Q4	$3K	Buy	5 +3	+150%	+$5.19K	﹤0.01%	7941
2015 Q3	$5K	Buy	2 +1	+100%	+$2.72K	﹤0.01%	7762
2015 Q2	$4K	Hold	1	–	–	﹤0.01%	8022
2015 Q1	$5K	Buy	+1	New	+$5.2K	﹤0.01%	8150

UBS Group's RNVA Position: Q4 2017 in Review

UBS Group sold out of Rennova Health, Inc. (RNVA) in Q4 2017, closing a stake of 2,218 shares — an estimated $6K sold.

UBS Group first reported a position in RNVA in Q1 2015 and held it in 9 quarters. The position peaked at $9K in Q2 2017. 1 fund tracked by Wall St. Rank holds RNVA as of Q4 2017.

UBS Group reported no remaining Rennova Health, Inc. position as of Q4 2017 after selling out during the quarter.
UBS Group sold 2,218 Rennova Health, Inc. shares in Q4 2017, an estimated $6K.
UBS Group first reported a position in Rennova Health, Inc. in Q1 2015 and held it in 9 quarters.
UBS Group's Rennova Health, Inc. position peaked at $9K in Q2 2017.
1 fund tracked by Wall St. Rank held Rennova Health, Inc. as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.